Low-Positive C-ANCA in Isolated Ocular Vasculitis: Limited Clinical Significance
This low-titer C-ANCA (1:20) with normal inflammatory markers in an isolated, self-resolved ocular presentation has minimal clinical significance and does not warrant systemic immunosuppression or indicate ANCA-associated vasculitis.
Interpretation of Laboratory Findings
The serologic profile argues strongly against active systemic vasculitis:
C-ANCA titer of 1:20 is extremely low and falls below the threshold typically associated with active ANCA-associated vasculitis (AAV). In granulomatosis with polyangiitis (GPA), PR3-directed c-ANCA is present in 80-90% of cases with active systemic disease, but sensitivity drops to only 50% in limited forms 11.
Normal ESR (14 mm/h) is incompatible with active vasculitis. Active AAV is characterized by elevated acute phase reactants including ESR and CRP 1. The absence of systemic inflammation makes active vasculitis highly unlikely.
Negative ANA helps exclude other autoimmune causes of retinal vasculitis, though ANA positivity in 45.7% of GPA patients has been associated with keratoconjunctivitis 2.
Clinical Context: Self-Resolved Presentation
The clinical picture further diminishes concern:
Two-year history with spontaneous partial resolution is inconsistent with progressive AAV, which typically demonstrates ongoing inflammation requiring immunosuppression 3.
Absence of systemic features is critical. While limited forms of GPA exist, the more widespread and severe the presentation, the more likely ANCA positivity becomes clinically meaningful 11. Your patient lacks the characteristic systemic symptoms (fatigue, weight loss, night sweats) that herald generalized disease 1.
Unilateral involvement is atypical for AAV-related ocular disease, which tends to be bilateral in 69.6% of cases 2.
False-Positive ANCA: Common Pitfall
Low-titer c-ANCA can occur in multiple non-vasculitic conditions 11:
- Inflammatory bowel disease
- Primary sclerosing cholangitis
- Rheumatoid arthritis
- Cystic fibrosis (80% have atypical c-ANCA with BPI as target antigen)
- Infections
The combined use of indirect immunofluorescence and antigen-specific assays (ELISA for PR3) minimizes false positives 4. Without PR3 or MPO specificity testing, this result cannot be interpreted as diagnostically significant.
Diagnostic Approach for True AAV-Related Ocular Disease
When AAV is genuinely suspected, the diagnosis requires 5:
- Highly suggestive clinical features (not present here)
- Objective evidence of vasculitis from histology (biopsy not mentioned)
- ANCA positivity with appropriate clinical context
In GPA with ocular involvement 26:
- Most common manifestations: scleritis/episcleritis (87%), keratoconjunctivitis (71.7%), proptosis (26.1%)
- Retinal vasculitis with exudates and hemorrhage occurs in only 15.2%
- 95.5% of ocular GPA cases are PR3-ANCA positive 7
- Uveitis shows association with disease activity (BVAS) 2
Recommended Management Strategy
For this patient specifically:
Do not initiate systemic immunosuppression based on this serologic finding alone. Treatment decisions should be based on clinical presentation and histologic findings, not ANCA results alone 4.
Obtain PR3 and MPO-specific testing via ELISA to clarify whether this represents true ANCA positivity or a false-positive immunofluorescence result 84.
Monitor for development of systemic features that would raise concern for evolving AAV:
- Sinonasal symptoms (persistent bleeding, crusting, septal perforation)
- Pulmonary symptoms (nodules, infiltrates, hemoptysis)
- Renal involvement (hematuria, proteinuria, rising creatinine)
- Constitutional symptoms (fever, weight loss, fatigue)
Ophthalmologic surveillance for recurrence or progression of retinal vasculitis, though the self-limited course suggests this is unlikely.
Consider alternative diagnoses for the original retinal vasculitis episode, including idiopathic isolated ocular vasculitis 9, infectious causes, or other inflammatory conditions.
Critical Caveat
If PR3-ANCA returns strongly positive with high titer, or if systemic symptoms develop, reassessment is mandatory. However, the current presentation—low-titer c-ANCA, normal inflammatory markers, self-resolved unilateral disease without systemic features—does not meet diagnostic criteria for AAV and does not warrant the toxicity of systemic immunosuppression 53.